Page last updated: 2024-08-24

aromasil and Carcinoma, Intraepithelial

aromasil has been researched along with Carcinoma, Intraepithelial in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bevers, TB	1
Baildam, A; Barr, L; Bundred, NJ; Cheung, KL; Cramer, A; Dixon, JM; Flint, P; Grassby, S; Johnson, R; Landberg, G; Morris, J; Renshaw, L; Turner, L; Young, O	1
Vogel, V	1

Reviews

1 review(s) available for aromasil and Carcinoma, Intraepithelial

Article	Year
Chemoprevention in breast cancer. Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:7 Topics: Age Factors; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Lobular; Female; Humans; Randomized Controlled Trials as Topic; Risk Factors; Tamoxifen	2005

Trials

1 trial(s) available for aromasil and Carcinoma, Intraepithelial

Article	Year
Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Mar-01, Volume: 16, Issue:5 Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Placebos; Pyrazoles; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sulfonamides	2010

Article

Year

Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Mar-01, Volume: 16, Issue:5

Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Placebos; Pyrazoles; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sulfonamides

2010

Other Studies

1 other study(ies) available for aromasil and Carcinoma, Intraepithelial

Article	Year
Breast cancer risk reduction therapy: the low-hanging fruit. Journal of the National Comprehensive Cancer Network : JNCCN, 2015, Volume: 13, Issue:4 Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast; Breast Neoplasms; Carcinoma in Situ; Female; Humans; Hyperplasia; Nitriles; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles	2015

Article

Year

Breast cancer risk reduction therapy: the low-hanging fruit.

Journal of the National Comprehensive Cancer Network : JNCCN, 2015, Volume: 13, Issue:4

Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast; Breast Neoplasms; Carcinoma in Situ; Female; Humans; Hyperplasia; Nitriles; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2015